chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue; Fever; Chills; This non-serious case was reported by a physician via sales rep and described the occurrence of fatigue in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   In APR-2023, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fatigue (Verbatim: Fatigue), fever (Verbatim: Fever) and chills (Verbatim: Chills). The outcome of the fatigue, fever and chills were resolved (duration 4 days).   It was unknown if the reporter considered the fatigue, fever and chills to be related to Shingrix.     It was unknown if the company considered the fatigue, fever and chills to be related to Shingrix.   Additional Information: GSK Receipt Date: 17-MAY-2023 The patient experienced fatigue, fever, chills after receiving dose of Shingrix which lasted for 4 days.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. Medical history and drug reactions or allergies were not specified. On unknown dates, the patients were vaccinated with doses of GARDASIL (dose, dose number, lot number and route of administration were not reported), which were exposed to temperatures outside of range. No adverse effects were reported. Concomitant medications were not specified. This is one of several reports received from the same reporter. Additional information is not expected, because the permission to contact was not given.
Please note the above Manufacturer for Bexsero is incorrect.  The correct manufacturer is GSK. After patient's clinic appointment, she went outside to wait in the family vehicle with the car off and the windows down while her Mother and sibling were in the clinic seeing another provider.   Patient's Mom notified me at 15:52 that patient had texted her from the car and asked if we had anything she could "throw up in".  I instructed Mom to have patient come back into clinic.  Patient was extremely pale.  Patient c/o nausea, dizziness/weakness and significant right arm pain.  BP:  70/42  P:  96 (Prior to vaccine administration BP: 102/62  P:  91 [which is what she normally runs]).  Glucose POC:  75. Pt was monitored, candy and Coca Cola provided to increase blood sugar.  Tolerated candy however, Coca Cola exacerbated nausea.  Pt was continually monitored in clinic until BP returned to normal (for her).  She continued w/dizziness and nausea.  Phenergan 25mg was administered IM @ 16:56.  Pt was monitored an additional 15 minutes.  Nausea improved; remained w/slight dizziness.  Pt was escorted to family vehicle.   Spoke w/at 17:51 and patient was sleeping. Spoke w/Mom @ 18:43 and patient was up, feeling better and eating. 8-8-19 @ 09:38 spoke w/Mom:  Patient was still feeling "woozy".  Blood glucose per Mom's glucometer was 124 and BP w/home monitor was 115/74   P:  95.  Continued to c/o right arm pain.
excrutiatingly painful, like take my breath away pain when moving arm; arm seems inflamed; arm feels warm and looks red; dull ache with soreness extends all through the muscle; tingling in upper arm/neck; arm hurt similar to the flu shot; A spontaneous report was received from a physician's assistant concerning a 43 year old, female patient who developed pain in extremity, injection site inflammation, injection site erythema, myalgia and paraesthesia.    The patient's medical history included Sjogren's syndrome. Concomitant product use was not provided by the reporter.   The patient received their first of two planned doses of mRNA-1273 (Lot # 025L20A) on  28 Dec 2020 intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   Physician's assisted reported after the patient received the Moderna Covid Vaccine on 28 Dec 2020 she complained of arm hurting "similar to the flu shot". When the patient woke up the next morning, she could barely move her arm, and turning her palm up or down was "excoriatingly painful, like take my breath away pain" that was felt in her arm and shoulder. The patient described her arm as inflamed and warm and red going up into her shoulder and neck with tingling and muscle pain in her shoulder blade and back. The patient reported she believes the inflammation is due from the muscles getting irritated. She described the pain as a "dull ache" with soreness that extends all through the muscle.   Treatment for the event included ibuprofen 600 mg every 8 hours and fexofenadine 180 mg tablet in the morning.   Action taken with mRNA-1273 in response to the events was not provided.   The events, pain in extremity, injection site inflammation, injection site erythema, myalgia and paraesthesia were considered recovering.   The reporter did not provide an assessment for the event, pain in extremity, injection site inflammation, injection site erythema, myalgia and paraesthesia; Reporter's Comments: This report concerns a 43-year old female patient who experienced non-serious events pain in extremity, injection site inflammation, injection site erythema, myalgia and paraesthesia, occurring within 2 days of her receiving the mRNA-1273 (Lot # 025L20A). Events were considered as recovering after treatment with ibuprofen. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Overnight chills; woke up with headache, fever 99-100, aching, irritability.
the day after the vaccine I had chest pains......never had them before......hope not to have them again.....very scarey
Patient presents with a fear of needles. Post vaccination, patient felt nauseous. Patient vomited and nausea dissipated. Patient was given crackers and juice in observation tent and reported improved symptoms.
Extreme fatigue and exhaustion. It is like my energy levels went down and can't come up, despite of food, water, and dietary supplement intake.
I experienced what I understand to be called "COVID arm". Swelling and rash at injection site.
Information has been received from a physician concerning a 50 year old male who on 14-MAY-2007 was vaccinated with a single subcutaneous dose of ProQuad. Concomitant medication included a "GAP injection" given on 14-May-2007. On 16-MAY-2007, the patient experienced redness and hardness of approximately a 3 square inch area on the inner left thigh. The patient was treated with injectable rocephin. No additional information was provided. Unspecified medical attention was sought. No product quality complaint was involved. The patients experiences were considered to be other important medial events by the reporter. Additional information has been requested.
Per patients mom, patient complained of Headache 10 mins postvaccination.  Developed Bilateral arm redness, sore and warm to touch getting larger the same day as vaccination. Patient applied ice to arms, took benadryl and motrin per mom.  Advised to have patient seen by family physician.  Pt saw family physician who per mom states patient is just having an allergic reaction, Dr. incresed patients benadryl dose.  On 7-28-09 phoned mom and she states patient is completely better headache is gone and arms are completely better no redness or swelling or soreness.
This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (benign tumor in front of right ear & help fund the process to figure out why mine shrank from the size of a nickel to the size of a BB with someone else's.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (benign tumor in front of right ear & help fund the process to figure out why mine shrank from the size of a nickel to the size of a BB with someone else's.). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (benign tumor in front of right ear & help fund the process to figure out why mine shrank from the size of a nickel to the size of a BB with someone else's.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant products were not provided. Treatment medication were not reported.
Mother called 5-23-2000 to report child had low grade fever and rash. Rash is fine, pinhead size, not raised and covers trunk, legs, arms, face, perineum.
diagnosed on 03Apr with covid; diagnosed on 03Apr with covid; This is a spontaneous report from a non-contactable consumer (wife). A 62-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient's medical history included memory issue. Concomitant medications were not reported. The patient was diagnosed with COVID on 03Apr2021. Patient wants to take the second shot. He was not underage, but he has some memory issues. He needs someone to be with him. Outcome of the event was unknown.   No follow-up attempts are possible, information about lot/batch number cannot been obtained.
Extreme body aches; Extreme fatigue; mild dehydration; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old patient of unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 23Mar2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included emtricitabine, tenofovir alafenamide fumarate, bictegravir sodium (BIKTARVY); taken for unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the right arm on 01Mar2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient had not been diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021, after second dose, the patient experienced extreme body aches, extreme fatigue and mild dehydration; all symptoms experienced for a full day and were gone the following day after that. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme body aches, extreme fatigue and mild dehydration were recovered on 25Mar2021.  No follow-up attempts are needed. No further information is expected.
Four days after the first dose, she started feeling a pinch or prick type of pain in her heart/chest area that radiated out and slowly dissipated. It would last a few minutes and happen without a specific interval several times a day for about four days.  After that, it didn?t happen again. We wanted to go to urgent care, but at the end didn?t go.
Fever 100-102, erythema mac/pap rash over injection site. There's no swelling or lumps at this x.
This patient did not have an adverse event but he was given 2 doses of Varicella. Our nurse accidentally pulled MMRV instead of MMR in combination with Varicella to give to this patient for his 4 month shots. We have informed the patient and called and checked up with the patient several times to ensure he does not or did not have a Adverse event.   *Note, i did not put a date in for question 5 since this patient did not have an adverse reaction.
After receiving 2 (two) of the Pfizer shots in early 2022  I had a slight stroke (vision was and still is affected) in March. Do you want this recorded? And what if anything should I now do?
She had lifelong chronic eczema and after she got the vaccine her eczema went away and completely gone; She had lifelong chronic eczema and after she got the vaccine her eczema went away and completely gone; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "chronic eczema" (not ongoing), notes: She had lifelong chronic eczema; "atopic dermatitis" (unspecified if ongoing), notes: she had very bad atopic dermatitis. The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), PRE-EXISTING CONDITION IMPROVED (non-serious), outcome "unknown" and all described as "She had lifelong chronic eczema and after she got the vaccine her eczema went away and completely gone".  Additional information: Patient's height was 5'5, a good estimate and weight was probably about 200 pounds, or maybe 180, so, 180 to 200 pounds. Patient got vaccine some time in 2021, noticed eczema improving. Before she got vaccine, was at point where she heard Pfizer made an eczema vaccine, was exploring that because, she had very bad atopic dermatitis. Wanted treatment, to find some solution. After she got vaccine, it started to improve. By 3 months, eczema was completely gone, never came back. Covid vaccine, patient had in 2021 was the Pfizer BioNTech Original Covid vaccine, not the Pfizer Bivalent Covid vaccine, as previously stated.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
R09.02 HYPOXIA 4/19/2023 ABDOMINAL PAIN R09.02 HYPOXIA 4/19/2023 SEPSIS WO ACUTE ORGAN DYSFUNCTION R09.02 HYPOXIA 4/19/2023 ADENOCARCINOMA, TAIL OF PANCREAS R09.02 HYPOXIA 4/19/2023 ABDOMINAL PAIN
Pt. verified. Flushed face & body. Weakness. Shortness of breath. Chest & back pain. Redness to neck, chest, and arms, nausea.
After administration of 2nd Pfizer vaccine, patient became dizzy/light headed. After laying down for 20 mins, patient began shivering, developed a headache, had numbness in hands, and was tired.  After about 30 mins with no improvement of symptoms, 911 was contacted. Paramedics arrived and gave patient EKG, BP, Temp, and Glucose. All were within normal limits.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided.  On or about 23-JUL-2015 the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster.  On or about 22-APR-2016 the patient was treated at a medical center for the onset of severe vesicular rash accompanied by a weakened immune symptoms, which was diagnosed as severe herpes zoster. The patient has been prescribed tramadol, acyclovir and trimethoprim and sulfamethoxazole (BACTRIM) for management of her painful condition. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.   Additional information has been requested.
Next day felt like flu symptoms hot/cold took Tylenol went to bed, next day felt better but now arm red, sore, hot to touch and swollen/ lump at injection site.  Also lump under armpit/sore,  applied ice & took ibuprofen, next day arm still ref/hot/lump, armpit still sore, but less of a lump.
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No Adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    No concomitant medication was reported.  190 patients (9 different lot numbers) received a vaccine past the beyond used by date.  It was unknown if patient received any other vaccines in the 4 weeks prior to the COVID-19 vaccine administration.  No treatment medication was reported.  This case contains information for the 76th of 190 patients described by the reporter.   This case was linked to MODERNATX, INC.-MOD-2023-704335 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MODERNATX, INC.-MOD-2023-704335:Master case
Information has been received from a physician concerning an unspecified patient (unknown age and gender). The patient's pertinent medical history and concurrent conditions were not provided. The physician reported that on 27-JUL-2016, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dosage and therapy route were not indicated), and on 08-AUG-2016 the patient received a second dose of ZOSTAVAX (lot #, expiration date, dosage and therapy route were not indicated). Concomitant therapies were not provided. No adverse reactions were reported. No product quality complaint (PQC) was involved at the time of the report. Additional information has been requested.
My COVID-19 symptoms were runny nose, and  scratchy throat.  On 12/07/2022 I was feeling sinus. On 12/082022 I did a COVID-19 home test which was positive. On Friday dry cough. On Saturday my taste bud was different  and my gums hurt .on the same day when I tested positive I called my doctor he prescribed me with Molnupiravir for 5 days 2 per day.  I felt better right after my first. On 12/14/2022 I had high blood pressure 193/99. It was very high.  I was hospitalized for a day. I called my doctor who prescribed me with Losartan and  Hydrochlorothiazide. I was also given Olmesartan. The doctor said it was complications of COVID-19.  My Blood pressure improved but not back to normal yet.
States left arm pain became progressively more painful to the touch during the day. In evening left arm pain was a "10" on scale of 1-10, pain radiated down arm to elbow and also into armpit. Pain somewhat relieved with Ibuprofen and heat. Client also complained of slight body ache and of feeling warm. Pain when lifting left arm.  Re-evaluated 48hours 3-4 cm area of red streak to axilla, warm.  Started on Levaquin 500 po BID for presumed cellulitis.
(L) arm became red and swollen. (+) tenderness. Patient was seen at ER on 6/7/08. Diagnosed with cellulitis and treated with antibiotic, Keflex.
15 day old infant received 2 months immunization. Patient record with baby not baby record. Informed mom of immunization information side effects including giving Tylenol 0.4 after shots if baby develop fever. Baby kept at clinic for further monitoring after shots given. Examined by provider. Exam within normal. 2-6-07 talked to father of baby states baby has a little fever but did not know how high.
Information has been received from a physician assistant concerning a male patient who on unspecified dates were vaccinated with "2 out of the 3 doses" of ROTATEQ (oral).  Subsequently the patient developed symptoms of ROTATEQ like vomiting and diarrhea that lasted for a couple of days.  At the time of the report, the patient recovered after a couple of days of having the symptoms.  No further information is available.
Headache, Myalgia, Arthralgia, Fever, CoughWheeze, UPPER RIGHT ARM PAIN WITH NUMBNESS TO  RIGHT INDEX FINGER, FATIGUE, SORE THROAT Narrative:
Information has been received from a physician concerning a 15 year old female who was vaccinated with a dose of Gardasil. Subsequently "few weeks ago" the patient experienced dizziness, headaches and blurred vision. Subsequently, the patient recovered from dizziness, headaches and blurred vision. Additional information has been requested. Information has been received from a physician concerning a 15  year old female who was vaccinated with a dose of HPV vaccine. Subsequently "few weeks ago" the patient experienced dizziness, headaches and blurred vision. Subsequently, the patient recovered from dizziness, headaches and blurred vision. Additional informatin has been requested.
belly button was infected; a lump under my chin; weight gain/started gaining a pound a day; This is a spontaneous report received from a contactable consumer (patient) received from a Pfizer sponsored program. A 67-years-old female patient received bnt162b2 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 17Mar2021 09:15 (Batch/Lot Number: EN6209) as SINGLE DOSE for covid-19 immunisation, 67 years old. Medical history included bipolar disorder and attention deficit hyperactivity disorder from Jun2016 which were controlled by unspecified medications. The patient's concomitant medications were not reported. She has not had any other recent vaccinations or started any new medications. The patient experienced belly button was infected and a lump under the chin on 18Mar2021; weight gain/started gaining a pound a day on Mar2021. Patient had her first shot on 17Mar2021, and all was well and there were no problems. Patient woke up the next morning with a lump under her chin and her belly button was infected. She was able to take care of the belly button but the lump under her chin has not gone away. She was going to seek medical advice for that. For the lump under her chin, she has done no treatment. For the belly button she has used hydrogen peroxide and some special stuff she has, an antibiotic cream, and took a Q-tip, which she is doing it on a daily basis and has not quit yet. She says it is fine not, now like in the beginning, which was pretty nasty. She says for the chin it was like "when you have bumped something, you usually know it is going to have a bump there or you would see something there, but she didn't bump anything, which is why she was confused". She stated she would think she had made it up in her head, but she did not. She stated she hasn't seen doctor yet; she will be going to the new facility to see a doctor to get his opinion.  The second dose would be given on 07Apr2021. The patient asked if others reported that quite odd side effect, what happens if she does not get the second dose, if there were reported issues of weight gain, it has never been an issue with her and she started gaining a pound a day, were there pre-historic animals used in the vaccine, and that she read that there is a chip in the vaccine. Outcome of the event "belly button was infected" was recovering, "a lump under the chin" was not recovered and "weight gain/started gaining a pound a day" was unknown.